Steven M. Chaouki - 31 Dec 2025 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Reporting relationship: Director
Issuer ticker: MAIA
Reported as of: 31 Dec 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Jan 2026, 08:36:41 UTC
Prior SEC filing: 23 Dec 2025
Next SEC filing: 05 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Steven M. Chaouki

Key filing fact

Steven M. Chaouki filed Form 4 for MAIA Biotechnology, Inc. (MAIA) on 05 Jan 2026.

Key facts

This page summarizes Steven M. Chaouki's Form 4 filing for MAIA Biotechnology, Inc. (MAIA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 05 Jan 2026, 08:36.

Change

Previous filing in this sequence was filed on 23 Dec 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001776865 Primary reporting owner

CHAOUKI STEVEN M

Relationship: Director
Address: 444 WEST LAKE STREET, SUITE 1700, CHICAGO
Signature: /s/ Steven M. Chaouki
Signature date: 05 Jan 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MAIA transaction Derivative

Options

Award

Transaction value: $0
Shares: +24,633
Change %
Price: $0.000000
Shares after: 24,633
Date: 31 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 24,633
Exercise price: $1.53
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock options, granted on December 31, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.